IJMS | Free Full-Text | A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Subtlety of the Structure−Affinity and Structure−Efficacy Relationships around a Nonpeptide Oxytocin Receptor Agonist | Journal of Medicinal Chemistry
Subtlety of the Structure−Affinity and Structure−Efficacy Relationships around a Nonpeptide Oxytocin Receptor Agonist | Journal of Medicinal Chemistry
The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies | SpringerLink
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
IJMS | Free Full-Text | The Role of Physical Exercise in Opioid Substitution Therapy: Mechanisms of Sequential Effects
The RGSZ2 Protein Exists in a Complex with μ-Opioid Receptors and Regulates the Desensitizing Capacity of Gz Proteins | Neuropsychopharmacology
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Kappa Agonists - an overview | ScienceDirect Topics
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
D3 Dopamine and Kappa Opioid Receptor Alterations in Human Brain of Cocaine‐overdose Victims - MASH - 1999 - Annals of the New York Academy of Sciences - Wiley Online Library
Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade | Neuropsychopharmacology
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain | Neuropsychopharmacology
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
